XTL BIOPHARMACEUTICALS-ADR (XTLB) Stock Price, Quote, News and Overview
NASDAQ:XTLB - Nasdaq - US98386D3070 - ADR - Currency: USD
XTLB Quote, Performance and Key Statistics
NASDAQ:XTLB (2/21/2025, 8:00:02 PM)
1.41
-0.1 (-6.62%)
The current stock price of XTLB is 1.41 USD. In the past month the price decreased by -25%. In the past year, price increased by 66.82%.
XTLB Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About XTLB
Company Profile
XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. The firm pipelines include hCDR1 systematic lupus erythematosus and recombinant human erythropoietin (rHuEPO) multiple myeloma. Its hCDR1, which is a potential treatment for systemic lupus erythematosus (SLE) and Sjogren's syndrome (SS). hCDR1 is a peptide that is administered subcutaneously and acts as a disease-specific treatment to modify the SLE-related autoimmune process. The rHuEPO known agent for anemia to prolong the survival of patients for the treatment of multiple myeloma blood cancer. Its Erythropoietin (EPO) is a glycoprotein hormone produced mainly by the kidney. EPO stimulates erythropoiesis, the production of red blood cells, by binding to its receptor on the surface of erythroid progenitor cells, promoting their proliferation and differentiation and maintaining their viability.
Company Info
XTL BIOPHARMACEUTICALS-ADR
5 Badner St., P.O.Box 8241
Ramat Gan 4365603 IL
CEO: Shlomo Shalev
Employees: 33
Company Website: https://www.xtlbio.com/
Investor Relations: http://www.xtlbio.com/investors/
Phone: 97299557080
XTL BIOPHARMACEUTICALS-ADR / XTLB FAQ
What is the stock price of XTL BIOPHARMACEUTICALS-ADR today?
The current stock price of XTLB is 1.41 USD. The price decreased by -6.62% in the last trading session.
What is the ticker symbol for XTL BIOPHARMACEUTICALS-ADR stock?
The exchange symbol of XTL BIOPHARMACEUTICALS-ADR is XTLB and it is listed on the Nasdaq exchange.
On which exchange is XTLB stock listed?
XTLB stock is listed on the Nasdaq exchange.
What is XTL BIOPHARMACEUTICALS-ADR worth?
XTL BIOPHARMACEUTICALS-ADR (XTLB) has a market capitalization of 7.68M USD. This makes XTLB a Nano Cap stock.
How many employees does XTL BIOPHARMACEUTICALS-ADR have?
XTL BIOPHARMACEUTICALS-ADR (XTLB) currently has 33 employees.
What are the support and resistance levels for XTL BIOPHARMACEUTICALS-ADR (XTLB) stock?
XTL BIOPHARMACEUTICALS-ADR (XTLB) has a resistance level at 1.74. Check the full technical report for a detailed analysis of XTLB support and resistance levels.
Should I buy XTL BIOPHARMACEUTICALS-ADR (XTLB) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of XTLB, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of XTLB, evaluating the profitability, health, valuation and growth aspects
- XTL BIOPHARMACEUTICALS-ADR (XTLB) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- XTL BIOPHARMACEUTICALS-ADR (XTLB) Sales and EPS estimates to see what analysts future expectations are.
- XTL BIOPHARMACEUTICALS-ADR (XTLB) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- XTL BIOPHARMACEUTICALS-ADR (XTLB) Insider and Institutional Ownership to learn about the owners and their transactions.
- XTL BIOPHARMACEUTICALS-ADR (XTLB) Stock Chart to make your own analysis
- XTL BIOPHARMACEUTICALS-ADR (XTLB) Latest news and press-releases to stay up to date.
Does XTL BIOPHARMACEUTICALS-ADR (XTLB) stock pay dividends?
XTLB does not pay a dividend.
What is the Short Interest ratio of XTL BIOPHARMACEUTICALS-ADR (XTLB) stock?
The outstanding short interest for XTL BIOPHARMACEUTICALS-ADR (XTLB) is 1.64% of its float. Check the ownership tab for more information on the XTLB short interest.
XTLB Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to XTLB. When comparing the yearly performance of all stocks, XTLB is one of the better performing stocks in the market, outperforming 86.34% of all stocks.
XTLB Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |